Agreements for Commercializing Technology (ACT) is a new business-friendly technology transfer tool offered at several DOE Laboratories. ACT differs from traditional lab partnership agreements because the laboratory contractor can accept terms and risks that the government is prohibited from accepting, such as offering a performance guarantee or taking on indemnification risk. In exchange for taking on risks the government is unable to accept, the Laboratory contractor is authorized to receive a fee from its R&D partner.
This mechanism was put in place in response to concerns that were raised in public responses to a Notice of Inquiry regarding Technology Transfer practices at U.S. Department of Energy (DOE) laboratories.
A new pilot, FedACT, expands the use of ACT to allow organizations that have received federal funding for R&D to partner with DOE’s National Labs.
|Description: Labs and a partner outside the federal government complete a project using specialized or unique facilities or expertise.|
|Typical Uses: To develop new products; To conduct scientific research; For partners that need flexible terms and conditions|
|Advantages: Flexible (negotiable terms and conditions on intellectual property provisions); Fast (10 day approval process); Gov’t may only retain a research license on IP; Easier to conduct multi-party research|
|Cost: Participant pays full cost, plus fees to contractor|
|Find a Lab|